[go: up one dir, main page]

ES2166829T3 - Composicion acuosa espumante. - Google Patents

Composicion acuosa espumante.

Info

Publication number
ES2166829T3
ES2166829T3 ES95925940T ES95925940T ES2166829T3 ES 2166829 T3 ES2166829 T3 ES 2166829T3 ES 95925940 T ES95925940 T ES 95925940T ES 95925940 T ES95925940 T ES 95925940T ES 2166829 T3 ES2166829 T3 ES 2166829T3
Authority
ES
Spain
Prior art keywords
foamy
composition
water
compositions
watery composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925940T
Other languages
English (en)
Inventor
Jean-Pierre Sachetto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tillotts Pharma AG
Original Assignee
Tillotts Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma AG filed Critical Tillotts Pharma AG
Application granted granted Critical
Publication of ES2166829T3 publication Critical patent/ES2166829T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PROPORCIONA UNA COMPOSICION ESPUMOSA ACUOSA QUE TIENE UNA ACCION ESPUMOSA RETARDADA A PARTIR DE LA EXPULSION DE UN CONTENEDOR PRESURIZADO, INCLUYENDO LA COMPOSICION: (A) UNA CANTIDAD MAYOR DE PESO DE AGUA; (B) UN AGENTE ESPUMOSO EN FORMA DE UN GAS LICUADO NO MEZCLABLE EN AGUA; (C) AL MENOS UN ESTABILIZANTE DE ESPUMA Y UN SURFACTANTE EMULSIONANTE; Y (D) UN POLIMERO SOLUBLE EN AGUA. LAS COMPOSICIONES DE LA INVENCION TIENEN UN USO ESPECIAL EN LA ADMINISTRACION RECTAL O VAGINAL DE MEDICAMENTOS. PARA USO MEDICO, LA COMPOSICION TAMBIEN CONTIENE UN INGREDIENTE ACTIVO. SI SE DESEA, SE PUEDE INCLUIR UN INGREDIENTE MUCO-ADHESIVO. SE PRESENTAN TAMBIEN OPCIONALMENTE ADITIVOS CONVENCIONALES PARA COMPOSICIONES FARMACEUTICAS.
ES95925940T 1994-07-21 1995-07-21 Composicion acuosa espumante. Expired - Lifetime ES2166829T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414699A GB9414699D0 (en) 1994-07-21 1994-07-21 Aqueous foamable composition

Publications (1)

Publication Number Publication Date
ES2166829T3 true ES2166829T3 (es) 2002-05-01

Family

ID=10758660

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925940T Expired - Lifetime ES2166829T3 (es) 1994-07-21 1995-07-21 Composicion acuosa espumante.

Country Status (18)

Country Link
US (2) US5759520A (es)
EP (1) EP0774957B1 (es)
JP (1) JP4199306B2 (es)
KR (1) KR970704423A (es)
CN (1) CN1158565A (es)
AT (1) ATE207737T1 (es)
AU (1) AU701373B2 (es)
BR (1) BR9508788A (es)
CZ (1) CZ291385B6 (es)
DE (1) DE69523602T2 (es)
ES (1) ES2166829T3 (es)
FI (1) FI970240A7 (es)
GB (1) GB9414699D0 (es)
HU (1) HUT77528A (es)
NO (1) NO315839B1 (es)
NZ (1) NZ289903A (es)
PL (1) PL318315A1 (es)
WO (1) WO1996003115A1 (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
WO1999016454A1 (en) * 1997-09-26 1999-04-08 Medeva Europe Limited Pharmaceutical composition for the treatment of inflammatory bowel disease
US6214318B1 (en) 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6286530B1 (en) * 1999-06-20 2001-09-11 Richard Hussey Reconfigurable sun shade and shelter apparatus
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20030065002A1 (en) * 2001-05-11 2003-04-03 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
ES2320748T5 (es) 2002-04-05 2017-02-20 Euro-Celtique S.A. Matriz para la liberación sostenida, invariable e independiente de compuestos activos
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
CA2504283A1 (en) * 2002-10-31 2004-05-21 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
MXPA06002163A (es) * 2003-08-25 2006-05-22 Foamix Ltd Espuma farmaceutica de penetracion.
US7201815B2 (en) * 2003-09-02 2007-04-10 H.B. Fuller Licensing & Financing Inc. Paper laminates manufactured using foamed adhesive systems
CA2528818C (en) * 2003-10-03 2010-08-10 Collegium Pharmaceutical, Inc. Topical aerosol foams
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
EP1699431B1 (en) 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
ZA200507019B (en) * 2004-04-28 2008-02-27 Foamix Ltd Body cavity foams
US8211449B2 (en) * 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
WO2006010589A2 (en) * 2004-07-29 2006-02-02 Mipharm S.P.A. Post foaming gel mousse
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
CA2609953A1 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
WO2007050543A2 (en) 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
WO2007082698A1 (en) * 2006-01-19 2007-07-26 Disphar International B.V. Foam-forming composition
EP1810666A1 (en) * 2006-01-19 2007-07-25 Ferring International Center S.A. Foam-Forming composition
US7915472B2 (en) * 2006-02-07 2011-03-29 Battelle Energy Alliance, Llc Surface decontamination compositions and methods
US7846888B2 (en) * 2006-02-07 2010-12-07 Battelle Energy Alliance, Llc Long lasting decontamination foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8652443B2 (en) 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
UY32487A (es) 2009-03-10 2010-06-30 Euro Celtique Sa Composiciones farmacéuticas de liberación inmediata comprendiendo oxicodona y naloxona
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
CN102512338A (zh) * 2012-01-13 2012-06-27 北京国联诚辉医药技术有限公司 一种水溶性人体润滑剂及其制备方法
US9402968B2 (en) 2012-07-11 2016-08-02 Mercy Medical Research Institute, Inc. Colorectal delivery device
US9499772B2 (en) 2013-03-13 2016-11-22 Battelle Energy Alliance, Llc Methods of decontaminating surfaces and related compositions
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
GB201905940D0 (en) 2019-04-29 2019-06-12 Intract Pharma Ltd 5-aminolevulinic acid for the local treatment of inflammatory bowel disease
GB201906906D0 (en) 2019-05-16 2019-07-03 Intract Pharma Ltd Novel compositions
GB201906917D0 (en) 2019-05-16 2019-07-03 Intract Pharma Ltd Novel compositions
GB202017863D0 (en) 2020-11-12 2020-12-30 Intract Pharma Ltd Novel compositions
GB202201708D0 (en) 2022-02-10 2022-03-30 Intract Pharma Ltd Compositions for oral delivery of biotherapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87449A1 (fr) * 1989-02-09 1990-09-19 Oreal Procede de fabrication de mousses utilisables dans les domaines cosmetique et pharmaceutique et mousses obtenues par ce procede
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (fr) * 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal
ATE124860T1 (de) * 1989-07-28 1995-07-15 Hisamitsu Pharmaceutical Co Schaumaerosolzusammensetzung.
SE9000485D0 (sv) * 1990-02-09 1990-02-09 Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
IT1243379B (it) * 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
IT1247529B (it) * 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
US5545401A (en) * 1994-06-02 1996-08-13 Shanbrom; Edward Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition

Also Published As

Publication number Publication date
JP4199306B2 (ja) 2008-12-17
NO970239D0 (no) 1997-01-20
NO970239L (no) 1997-01-20
NO315839B1 (no) 2003-11-03
AU701373B2 (en) 1999-01-28
KR970704423A (ko) 1997-09-06
PL318315A1 (en) 1997-06-09
AU2988095A (en) 1996-02-22
DE69523602T2 (de) 2002-06-20
HUT77528A (hu) 1998-05-28
ATE207737T1 (de) 2001-11-15
MX9700521A (es) 1998-05-31
FI970240L (fi) 1997-03-20
EP0774957B1 (en) 2001-10-31
CN1158565A (zh) 1997-09-03
BR9508788A (pt) 1997-11-25
GB9414699D0 (en) 1994-09-07
FI970240A0 (fi) 1997-01-20
CZ291385B6 (cs) 2003-02-12
FI970240A7 (fi) 1997-03-20
US5972310A (en) 1999-10-26
US5759520A (en) 1998-06-02
NZ289903A (en) 1998-10-28
WO1996003115A1 (en) 1996-02-08
EP0774957A1 (en) 1997-05-28
JPH11503716A (ja) 1999-03-30
CZ17197A3 (en) 1997-07-16
DE69523602D1 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
ES2166829T3 (es) Composicion acuosa espumante.
US6268322B1 (en) Dual chamber cleansing system, comprising multiple emulsion
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2182357T3 (es) Nueva utilizacion de budesonide y formoterol.
ES2101330T3 (es) Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado.
ECSP044974A (es) Formulación de suspensión oral estabilizada
AR032352A1 (es) Composicion farmaceutica bioadhesiva de hidratacion gradual y su uso en la fabricacion de un medicamento para la administracion de testosterona y terbutalina a un mamifero a traves de una superficie de mucosa.
ES2175799T3 (es) Forma de dosificacion para administracion en aerosol.
AR030253A1 (es) Sistemas de suministro de drogas autoemulsionantes para drogas lipofilicas extremadamente insolubles en agua, una formulacion y el uso de una composicion para la fabricacion de un medicamento
AR036066A2 (es) Metodo para suministrar una droga a un ojo humano
ES2187749T3 (es) Composicion agroquimica envasada.
AR023158A1 (es) Composiciones desodorantes liquidas para todo proposito
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
AR021595A1 (es) Composiciones y metodos para tratar cabello y piel utilizando sistemas de suministro acuoso.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BRPI0414883A (pt) composição, concentrado de composição, e, composições alcoólicas desinfetante e semelhante a gel
ES2182303T3 (es) Configuraciones reguladoras del flujo para un dispositivo de administracion de agents activos.
BR9906372A (pt) Composição farmaceutica aquosa para aplicação na mucosa
EP1354590A4 (en) MEDICINES AGAINST JOINT DEFECTS
MXPA03001762A (es) Proceso para preparar composiciones farmaceuticas para uso con formulaciones de gelatina suave.
PE20021017A1 (es) Composicion parenteral reconstituible
CY1110052T1 (el) Η χρηση της πολυαιθυλενογλυκολης (peg) για την κατασκευη φαρμακου για τη θεραπεια της δυσκοιλιοτητας
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
WO2002026191A3 (en) Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue